Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PULSE BIOSCIENCES, INC.PLSE · Entity 1151 | Chief Strategy Officer | September 24, 2024 | September 30, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PULSE BIOSCIENCES, INC.
Report date September 24, 2024 · Filed September 30, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 93,880 |
Reported balance
After 2024-09-24 transaction · row 1
1 source rowRow 1 · 2024-09-24 · Other · Acquired 3,000 · Balance 93,880 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Common StockSEC Table I · non-derivative | IndirectSpouse | 21,240 |
Reported balance
After 2024-09-24 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2024-09-24 · Other · Acquired 1,240 · Balance 21,240 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Common StockSEC Table I · non-derivative | IndirectImmediate Family Member 1 | 8,321 |
Reported balance
After 2024-09-24 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2024-09-24 · Other · Acquired 322 · Balance 8,321 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Common StockSEC Table I · non-derivative | IndirectImmediate Family Member 2 | 8,421 |
Reported balance
After 2024-09-24 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2024-09-24 · Other · Acquired 322 · Balance 8,421 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Common StockSEC Table I · non-derivative | IndirectImmediate Family Member 3 | 8,521 |
Reported balance
After 2024-09-24 transaction · row 5
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 5 · 2024-09-24 · Other · Acquired 322 · Balance 8,521 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-07-03 | Direct | 0 |
Reported balance
After 2024-09-24 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2024-09-24 · Other · Disposed 1,500 · Balance 0 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-07-03 | Direct | 0 |
Reported balance
After 2024-09-24 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2024-09-24 · Other · Disposed 1,500 · Balance 0 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-07-03 | IndirectSpouse | 1 |
Reported balance
After 2024-09-24 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2024-09-24 · Other · Disposed 620 · Balance 1 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-07-03 | IndirectSpouse | 1 |
Reported balance
After 2024-09-24 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2024-09-24 · Other · Disposed 620 · Balance 1 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-07-03 | IndirectImmediate Family Member 1 | 0 |
Reported balance
After 2024-09-24 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2024-09-24 · Other · Disposed 161 · Balance 0 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-07-03 | IndirectImmediate Family Member 1 | 0 |
Reported balance
After 2024-09-24 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2024-09-24 · Other · Disposed 161 · Balance 0 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-07-03 | IndirectImmediate Family Member 2 | 0 |
Reported balance
After 2024-09-24 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2024-09-24 · Other · Disposed 161 · Balance 0 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-07-03 | IndirectImmediate Family Member 2 | 0 |
Reported balance
After 2024-09-24 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2024-09-24 · Other · Disposed 161 · Balance 0 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-07-03 | IndirectImmediate Family Member 3 | 0 |
Reported balance
After 2024-09-24 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2024-09-24 · Other · Disposed 161 · Balance 0 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-07-03 | IndirectImmediate Family Member 3 | 0 |
Reported balance
After 2024-09-24 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2024-09-24 · Other · Disposed 161 · Balance 0 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC.
F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 25, 2023 Filed Jun 13, 2023 17:26 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 814 | $2.05 | $1,668.70 |
DisclosureSEC source: 0001437749-23-017296 · rdgdoc.xml · nonDerivative · entry 2 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Spouse Disclosed balance after: 4,135 Read SEC document |
| May 25, 2023 Filed Jun 13, 2023 17:26 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 10,935 | $2.05 | $22,416.75 |
DisclosureSEC source: 0001437749-23-017296 · rdgdoc.xml · nonDerivative · entry 1 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,843 Read SEC document |
| May 25, 2023 Filed Jul 6, 2023 20:32 UTC Amendment | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherWarrant (right to buy) · Derivative | 143 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0001437749-23-019537 · rdgdoc.xml · derivative · entry 10 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate family member Disclosed balance after: 0 Underlying: Common Stock · 143 shares Expires 2027-06-09 Read SEC document |
| May 25, 2023 Filed Jul 6, 2023 20:32 UTC Amendment | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherWarrant (right to buy) · Derivative | 143 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0001437749-23-019537 · rdgdoc.xml · derivative · entry 9 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate family member Disclosed balance after: 0 Underlying: Common Stock · 143 shares Expires 2027-06-09 Read SEC document |
| May 25, 2023 Filed Jul 6, 2023 20:32 UTC Amendment | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherWarrant (right to buy) · Derivative | 143 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0001437749-23-019537 · rdgdoc.xml · derivative · entry 8 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate family member Disclosed balance after: 0 Underlying: Common Stock · 143 shares Expires 2027-06-09 Read SEC document |
| May 25, 2023 Filed Jul 6, 2023 20:32 UTC Amendment | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherWarrant (right to buy) · Derivative | 814 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0001437749-23-019537 · rdgdoc.xml · derivative · entry 7 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Spouse Disclosed balance after: 0 Underlying: Common Stock · 814 shares Expires 2027-06-09 Read SEC document |
| May 25, 2023 Filed Jul 6, 2023 20:32 UTC Amendment | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherWarrant (right to buy) · Derivative | 10,935 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0001437749-23-019537 · rdgdoc.xml · derivative · entry 6 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,935 shares Expires 2027-06-09 Read SEC document |
| May 25, 2023 Filed Jul 6, 2023 20:32 UTC Amendment | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 143 | $2.05 | $293.15 |
DisclosureSEC source: 0001437749-23-019537 · rdgdoc.xml · nonDerivative · entry 5 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate family member Disclosed balance after: 734 Read SEC document |
| May 25, 2023 Filed Jul 6, 2023 20:32 UTC Amendment | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 143 | $2.05 | $293.15 |
DisclosureSEC source: 0001437749-23-019537 · rdgdoc.xml · nonDerivative · entry 4 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate family member Disclosed balance after: 734 Read SEC document |
| May 25, 2023 Filed Jul 6, 2023 20:32 UTC Amendment | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 143 | $2.05 | $293.15 |
DisclosureSEC source: 0001437749-23-019537 · rdgdoc.xml · nonDerivative · entry 3 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate family member Disclosed balance after: 734 Read SEC document |
| May 25, 2023 Filed Jul 6, 2023 20:32 UTC Amendment | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 814 | $2.05 | $1,668.70 |
DisclosureSEC source: 0001437749-23-019537 · rdgdoc.xml · nonDerivative · entry 2 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Spouse Disclosed balance after: 4,135 Read SEC document |
| May 25, 2023 Filed Jul 6, 2023 20:32 UTC Amendment | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 10,935 | $2.05 | $22,416.75 |
DisclosureSEC source: 0001437749-23-019537 · rdgdoc.xml · nonDerivative · entry 1 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,766 F1 · balance_after: The number of shares beneficially owned, as reported on the Form 4 filed on June 13, 2023, erroneously included options held by the Reporting Person. Read SEC document |
| May 08, 2023 Filed May 9, 2023 21:46 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | GrantStock Option (right to buy) · Derivative | 17,700 | Not disclosed Strike: $8.02 | Not disclosed |
DisclosureSEC source: 0001437749-23-013390 · rdgdoc.xml · derivative · entry 1 Levinson Mitchell E. · CIK 0001674465 · Director · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,700 Underlying: Common Stock · 17,700 shares Expires 2033-05-08 F2 · price: Not applicable. F1 · derivative.exercise_date: The option was granted on May 8, 2023 under the Issuer's 2017 Equity Incentive Plan. The shares subject to the option are subject to performance-based vesting criteria. 4,425 shares will vest in equal annual installments over the following four years, subject to achievement of the vesting criteria and the reporting person's continued service through each vesting date. Read SEC document |
| April 17, 2023 Filed May 9, 2023 21:46 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | GrantStock Option (right to buy) · Derivative | 2,000 | Not disclosed Strike: $5.81 | Not disclosed |
DisclosureSEC source: 0001437749-23-013390 · rdgdoc.xml · derivative · entry 2 Levinson Mitchell E. · CIK 0001674465 · Director · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2033-04-17 F2 · price: Not applicable. Read SEC document |
| March 22, 2023 Filed Mar 24, 2023 16:30 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | GrantStock Option (right to buy) · Derivative | 35,000 | Not disclosed Strike: $2.92 | Not disclosed |
DisclosureSEC source: 0001437749-23-007821 · rdgdoc.xml · derivative · entry 1 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2033-03-22 F2 · price: Not Applicable F1 · derivative.exercise_date: The option was granted on March 22, 2023 under the Issuer's 2017 Equity Incentive Plan. The shares subject to the option are subject to performance-based vesting criteria. 8,750 shares will vest in equal annual installments over the following four years on or about December 31, starting in 2023, subject to achievement of the vesting criteria and the reporting person's continued service through each vesting date. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 19:11 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseCommon Stock | 4,300 | $2.29 | $9,847.00 |
DisclosureSEC source: 0001387131-22-010379 · levinson-form4_100722.xml · nonDerivative · entry 5 Levinson Mitchell E. · CIK 0001674465 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate family member Disclosed balance after: 5,034 Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 19:11 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseCommon Stock | 4,500 | $2.23 | $10,035.00 |
DisclosureSEC source: 0001387131-22-010379 · levinson-form4_100722.xml · nonDerivative · entry 4 Levinson Mitchell E. · CIK 0001674465 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate family member Disclosed balance after: 5,234 Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 19:11 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseCommon Stock | 4,400 | $2.26 | $9,944.00 |
DisclosureSEC source: 0001387131-22-010379 · levinson-form4_100722.xml · nonDerivative · entry 3 Levinson Mitchell E. · CIK 0001674465 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate family member Disclosed balance after: 5,134 Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 19:11 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseCommon Stock | 8,810 | $2.27 | $19,998.70 |
DisclosureSEC source: 0001387131-22-010379 · levinson-form4_100722.xml · nonDerivative · entry 2 Levinson Mitchell E. · CIK 0001674465 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Disclosed balance after: 12,945 Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 19:11 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseCommon Stock | 8,770 | $2.29 | $20,083.30 |
DisclosureSEC source: 0001387131-22-010379 · levinson-form4_100722.xml · nonDerivative · entry 1 Levinson Mitchell E. · CIK 0001674465 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,274 Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 18:58 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseWarrant (right to buy) · Derivative | 143 | Not disclosed Strike: $2.05 | Not disclosed |
DisclosureSEC source: 0001387131-22-006922 · levinson-form4_060922.xml · derivative · entry 10 Levinson Mitchell E. · CIK 0001674465 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate family member Disclosed balance after: 143 Underlying: Common Stock · 143 shares Expires 2027-06-09 F2 · derivative.exercise_price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $2.05 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock at an exercise price of $2.05. F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 18:58 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseWarrant (right to buy) · Derivative | 143 | Not disclosed Strike: $2.05 | Not disclosed |
DisclosureSEC source: 0001387131-22-006922 · levinson-form4_060922.xml · derivative · entry 9 Levinson Mitchell E. · CIK 0001674465 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate family member Disclosed balance after: 143 Underlying: Common Stock · 143 shares Expires 2027-06-09 F2 · derivative.exercise_price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $2.05 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock at an exercise price of $2.05. F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 18:58 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseWarrant (right to buy) · Derivative | 143 | Not disclosed Strike: $2.05 | Not disclosed |
DisclosureSEC source: 0001387131-22-006922 · levinson-form4_060922.xml · derivative · entry 8 Levinson Mitchell E. · CIK 0001674465 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate family member Disclosed balance after: 143 Underlying: Common Stock · 143 shares Expires 2027-06-09 F2 · derivative.exercise_price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $2.05 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock at an exercise price of $2.05. F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 18:58 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseWarrant (right to buy) · Derivative | 814 | Not disclosed Strike: $2.05 | Not disclosed |
DisclosureSEC source: 0001387131-22-006922 · levinson-form4_060922.xml · derivative · entry 7 Levinson Mitchell E. · CIK 0001674465 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Disclosed balance after: 814 Underlying: Common Stock · 814 shares Expires 2027-06-09 F2 · derivative.exercise_price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $2.05 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock at an exercise price of $2.05. F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 18:58 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseWarrant (right to buy) · Derivative | 10,935 | Not disclosed Strike: $2.05 | Not disclosed |
DisclosureSEC source: 0001387131-22-006922 · levinson-form4_060922.xml · derivative · entry 6 Levinson Mitchell E. · CIK 0001674465 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,935 Underlying: Common Stock · 10,935 shares Expires 2027-06-09 F2 · derivative.exercise_price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $2.05 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock at an exercise price of $2.05. F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 18:58 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 143 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001387131-22-006922 · levinson-form4_060922.xml · nonDerivative · entry 5 Levinson Mitchell E. · CIK 0001674465 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate family member Disclosed balance after: 734 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $2.05 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock at an exercise price of $2.05. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 18:58 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 143 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001387131-22-006922 · levinson-form4_060922.xml · nonDerivative · entry 4 Levinson Mitchell E. · CIK 0001674465 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate family member Disclosed balance after: 734 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $2.05 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock at an exercise price of $2.05. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 18:58 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 143 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001387131-22-006922 · levinson-form4_060922.xml · nonDerivative · entry 3 Levinson Mitchell E. · CIK 0001674465 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate family member Disclosed balance after: 734 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $2.05 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock at an exercise price of $2.05. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 18:58 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 814 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001387131-22-006922 · levinson-form4_060922.xml · nonDerivative · entry 2 Levinson Mitchell E. · CIK 0001674465 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Disclosed balance after: 4,135 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $2.05 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock at an exercise price of $2.05. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 18:58 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 10,935 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001387131-22-006922 · levinson-form4_060922.xml · nonDerivative · entry 1 Levinson Mitchell E. · CIK 0001674465 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,504 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $2.05 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock at an exercise price of $2.05. Read SEC document |
| August 19, 2021 Filed Aug 20, 2021 16:22 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | GrantStock Option (right to buy) · Derivative | 65,510 | $0.00 Strike: $21.12 | $0.00 |
DisclosureSEC source: 0001209191-21-052766 · doc4.xml · derivative · entry 1 Levinson Mitchell E. · CIK 0001674465 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,510 Underlying: Common Stock · 65,510 shares Expires 2031-08-19 F1 · derivative.exercise_date: 50% of the shares subject to the option will vest in equal annual installments on the second, third and fourth anniversary of the grant date, and the other 50% of the shares subject to the option will vest upon the achievement of performance objectives established by the Compensation Committee of the Issuer, with vesting targets set at 25% (8,188 option shares) over the following four years on the anniversary of the grant date. All vesting is subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| May 20, 2021 Filed May 21, 2021 17:06 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | GrantStock Option (right to buy) · Derivative | 45,987 | $0.00 Strike: $18.69 | $0.00 |
DisclosureSEC source: 0001209191-21-035007 · doc4.xml · derivative · entry 2 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,987 Underlying: Common Stock · 45,987 shares Expires 2031-05-20 F2 · derivative.exercise_date: The shares subject to the option will vest in equal quarterly installments over a one year period, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| May 20, 2021 Filed May 21, 2021 17:06 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $18.69 | $0.00 |
DisclosureSEC source: 0001209191-21-035007 · doc4.xml · derivative · entry 1 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-05-20 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| January 20, 2021 Filed Jan 27, 2021 21:02 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherWarrant (right to buy) · Derivative | 19 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0001209191-21-005805 · doc4.xml · derivative · entry 9 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate family member Disclosed balance after: 0 Underlying: Common Stock · 19 shares Expires 2025-06-15 Read SEC document |
| January 20, 2021 Filed Jan 27, 2021 21:02 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherWarrant (right to buy) · Derivative | 19 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0001209191-21-005805 · doc4.xml · derivative · entry 8 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate family member Disclosed balance after: 0 Underlying: Common Stock · 19 shares Expires 2025-06-15 Read SEC document |
| January 20, 2021 Filed Jan 27, 2021 21:02 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherWarrant (right to buy) · Derivative | 19 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0001209191-21-005805 · doc4.xml · derivative · entry 7 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate family member Disclosed balance after: 0 Underlying: Common Stock · 19 shares Expires 2025-06-15 Read SEC document |
| January 20, 2021 Filed Jan 27, 2021 21:02 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherWarrant (right to buy) · Derivative | 107 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0001209191-21-005805 · doc4.xml · derivative · entry 6 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Disclosed balance after: 0 Underlying: Common Stock · 107 shares Expires 2025-06-15 Read SEC document |
| January 20, 2021 Filed Jan 27, 2021 21:02 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 19 | $7.01 | $133.19 |
DisclosureSEC source: 0001209191-21-005805 · doc4.xml · nonDerivative · entry 5 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate family member Disclosed balance after: 591 Read SEC document |
| January 20, 2021 Filed Jan 27, 2021 21:02 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 19 | $7.01 | $133.19 |
DisclosureSEC source: 0001209191-21-005805 · doc4.xml · nonDerivative · entry 4 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate family member Disclosed balance after: 591 Read SEC document |
| January 20, 2021 Filed Jan 27, 2021 21:02 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 19 | $7.01 | $133.19 |
DisclosureSEC source: 0001209191-21-005805 · doc4.xml · nonDerivative · entry 3 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate family member Disclosed balance after: 591 Read SEC document |
| January 20, 2021 Filed Jan 27, 2021 21:02 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 107 | $7.01 | $750.07 |
DisclosureSEC source: 0001209191-21-005805 · doc4.xml · nonDerivative · entry 2 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Disclosed balance after: 3,321 Read SEC document |
| October 08, 2020 Filed Dec 23, 2020 16:20 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherWarrant (right to buy) · Derivative | 856 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0001209191-20-065010 · doc4.xml · derivative · entry 6 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 856 shares Expires 2025-06-15 Read SEC document |
| October 08, 2020 Filed Dec 23, 2020 16:20 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 856 | $7.01 | $6,000.56 |
DisclosureSEC source: 0001209191-20-065010 · doc4.xml · nonDerivative · entry 1 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,569 Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 16:05 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseWarrant (right to buy) · Derivative | 19 | Not disclosed Strike: $7.01 | Not disclosed |
DisclosureSEC source: 0001209191-20-037225 · doc4.xml · derivative · entry 10 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate family member Disclosed balance after: 19 Underlying: Common Stock · 19 shares Expires 2025-06-15 F1 · kind: The Reporting Person acquired the shares and warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering, as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares and warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering, as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 16:05 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseWarrant (right to buy) · Derivative | 19 | Not disclosed Strike: $7.01 | Not disclosed |
DisclosureSEC source: 0001209191-20-037225 · doc4.xml · derivative · entry 9 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate family member Disclosed balance after: 19 Underlying: Common Stock · 19 shares Expires 2025-06-15 F1 · kind: The Reporting Person acquired the shares and warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering, as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares and warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering, as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 16:05 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseWarrant (right to buy) · Derivative | 19 | Not disclosed Strike: $7.01 | Not disclosed |
DisclosureSEC source: 0001209191-20-037225 · doc4.xml · derivative · entry 8 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate family member Disclosed balance after: 19 Underlying: Common Stock · 19 shares Expires 2025-06-15 F1 · kind: The Reporting Person acquired the shares and warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering, as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares and warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering, as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 16:05 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseWarrant (right to buy) · Derivative | 107 | Not disclosed Strike: $7.01 | Not disclosed |
DisclosureSEC source: 0001209191-20-037225 · doc4.xml · derivative · entry 7 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Disclosed balance after: 107 Underlying: Common Stock · 107 shares Expires 2025-06-15 F1 · kind: The Reporting Person acquired the shares and warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering, as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares and warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering, as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 16:05 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseWarrant (right to buy) · Derivative | 856 | Not disclosed Strike: $7.01 | Not disclosed |
DisclosureSEC source: 0001209191-20-037225 · doc4.xml · derivative · entry 6 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 856 Underlying: Common Stock · 856 shares Expires 2025-06-15 F1 · kind: The Reporting Person acquired the shares and warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering, as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares and warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering, as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 16:05 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 127 | $7.01 | $890.27 |
DisclosureSEC source: 0001209191-20-037225 · doc4.xml · nonDerivative · entry 5 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate family member Disclosed balance after: 572 F1 · kind: The Reporting Person acquired the shares and warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering, as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 16:05 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 127 | $7.01 | $890.27 |
DisclosureSEC source: 0001209191-20-037225 · doc4.xml · nonDerivative · entry 4 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate family member Disclosed balance after: 572 F1 · kind: The Reporting Person acquired the shares and warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering, as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.